C. diff (short for Clostridioides difficile) is a bacterium that infects the colon, causing inflammation, watery diarrhea, and in severe cases, life-threatening complications. It affects roughly 117 out of every 100,000 people in the United States each year, and it is one of the most common healthcare-associated infections in the country. Most cases are triggered by antibiotic use, which wipes out the protective bacteria in your gut and gives C. diff room to thrive.
How C. Diff Damages the Gut
C. diff doesn’t cause harm just by being present. The bacterium produces two toxins that do the actual damage to your intestinal lining. These toxins enter the cells that line your colon and disable proteins responsible for maintaining cell structure. Once those proteins are knocked out, the cells round up, blister, and eventually die.
That cell death does two things. First, it breaks apart the tight junctions between cells, essentially poking holes in the intestinal barrier. Fluid leaks into the colon, producing the watery diarrhea that defines the infection. Second, dying cells trigger a cascade of inflammation: immune cells flood the area, inflammatory signaling molecules ramp up, and reactive oxygen compounds cause further tissue damage. This is why C. diff doesn’t just cause loose stools. It causes genuine colitis, with swelling, redness, and sometimes visible patches of yellowish-white debris (called pseudomembranes) coating the colon wall.
Why Antibiotics Are the Main Trigger
Your colon normally hosts trillions of bacteria that crowd out harmful organisms like C. diff. Antibiotics disrupt that balance. When you take a broad-spectrum antibiotic for a sinus infection, urinary tract infection, or surgery, it kills beneficial gut bacteria along with the targeted pathogen. C. diff, which forms tough spores that survive antibiotic exposure, can then germinate and multiply without competition.
Not all antibiotics carry the same risk. Clindamycin is the single highest-risk antibiotic, with an odds ratio above 25 compared to no antibiotic use. Later-generation cephalosporins (commonly prescribed for respiratory and urinary infections) carry the next highest risk, with odds ratios between 8 and 12. Fluoroquinolones like ciprofloxacin fall in a middle tier, with an odds ratio around 7. Some antibiotics pose relatively low risk: the tetracycline-class drugs minocycline and doxycycline are among the safest in terms of C. diff likelihood.
Other factors raise your odds beyond antibiotics. Being over 65, spending time in a hospital or nursing facility, having a weakened immune system, and taking acid-reducing medications like proton pump inhibitors all increase vulnerability. But antibiotic exposure remains the dominant risk factor in the vast majority of cases.
Symptoms: Mild to Severe
The hallmark symptom is watery diarrhea, often three or more loose stools per day, sometimes with a distinctly foul odor. Mild to moderate cases typically include lower abdominal cramping, low-grade fever, and nausea. Symptoms usually begin within 5 to 10 days of starting an antibiotic, though they can appear weeks after finishing a course.
Severe infections produce higher fevers (above 101.3°F), significant abdominal pain and tenderness, and dehydration. Clinicians look for a white blood cell count above 15,000 and elevated creatinine as markers that the infection has crossed into severe territory. In the most dangerous form, called fulminant C. diff, blood pressure drops, the colon stops moving normally (ileus), and the abdomen becomes distended and rigid. This stage requires emergency care.
Toxic Megacolon and Other Complications
The most feared complication is toxic megacolon, which occurs in roughly 0.4% to 3% of C. diff cases. The colon dilates dramatically, loses its ability to contract, and becomes at risk of perforation. Signs include severe abdominal distension, rapid breathing, low blood pressure, high fever, and a sharply elevated white blood cell count. Paradoxically, diarrhea sometimes stops in these cases because the colon has essentially shut down.
If the colon perforates, bacteria spill into the abdominal cavity, causing peritonitis and sepsis. Surgery to remove part or all of the colon may be necessary if there’s no improvement within 48 to 72 hours, if the colon continues to expand, or if perforation or uncontrolled bleeding develops.
How C. Diff Is Diagnosed
Diagnosis starts with a stool sample. Two main types of tests are used, and they have different strengths. PCR-based tests (also called nucleic acid amplification tests) are highly sensitive and can detect the genes for C. diff toxins the same day. The downside is that PCR can pick up people who carry the organism without having an active infection, since it detects the genetic material rather than the toxin itself.
Toxin immunoassays directly detect the harmful toxins in stool, which means a positive result is strong evidence of active disease. However, these tests are less sensitive than PCR and can miss some true infections. Many hospitals now use a two-step approach: a sensitive screening test first, followed by a toxin-specific test to confirm active disease. Testing should only be done on unformed (liquid) stool. Testing formed stool leads to misleading results.
Treatment for Initial Infections
The first step, whenever possible, is stopping the antibiotic that triggered the infection. This alone can resolve mild cases. When treatment is needed, current guidelines favor fidaxomicin as the preferred option over vancomycin for an initial episode, primarily because it leads to fewer recurrences. Both are taken by mouth for 10 days. Vancomycin remains a fully acceptable alternative and is widely used.
For fulminant cases with dangerously low blood pressure, colon paralysis, or megacolon, higher doses of vancomycin are used, sometimes delivered directly into the colon if the patient can’t swallow. These patients are managed in a hospital setting, often in intensive care.
Most people with a first episode respond well to treatment within a few days, though diarrhea may take a week or more to fully resolve. The bigger concern is what happens after treatment ends.
Recurrence Is Common
Up to 30% of people who recover from a first C. diff infection will experience a recurrence, typically within 2 to 8 weeks of finishing treatment. The risk climbs with each subsequent episode: once you’ve had two infections, the chance of a third is even higher. This happens because the underlying problem, a disrupted gut microbiome, hasn’t been fully corrected. The same conditions that allowed C. diff to take hold the first time persist.
Fidaxomicin’s advantage over vancomycin is most apparent here. It is narrower in its effects on other gut bacteria, which helps the microbiome recover faster and reduces the odds of relapse. For patients who do experience multiple recurrences, fecal microbiota transplantation (FMT) is an option. FMT introduces a healthy donor’s gut bacteria into the patient’s colon, essentially resetting the microbial community. Studies have shown overall success rates around 75% for recurrent cases, with many patients improving within the first two months. The FDA has also approved standardized microbiota-based products specifically for preventing recurrence after antibiotic treatment.
Why Spores Make C. Diff Hard to Control
C. diff forms spores, dormant structures with a tough outer shell that makes them extraordinarily resilient. Spores survive for months on surfaces like bed rails, bathroom fixtures, doorknobs, and medical equipment. They resist alcohol-based hand sanitizers entirely and persist through many standard cleaning agents. This is why hospitals dealing with C. diff outbreaks emphasize handwashing with soap and water (the physical friction removes spores from skin) and use bleach-based disinfectants on surfaces.
If you’re caring for someone with C. diff at home, soap-and-water handwashing after any contact is essential. Alcohol gel, which works well against many other pathogens, does nothing to C. diff spores. Bathrooms shared with an infected person should be cleaned with a diluted bleach solution or a product labeled as effective against C. diff spores. Spores can also be shed by people who have recovered from symptoms, so good hygiene practices should continue for several weeks after the infection clears.